Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Montelukast sodium by Jiangyin Berrysen Pharmaceutical for Cervical Cancer: Likelihood of Approval
Montelukast sodium is under clinical development by Jiangyin Berrysen Pharmaceutical and currently in Phase II for Cervical Cancer. According to...
Montelukast sodium by Jiangyin Berrysen Pharmaceutical for Radiation Injury: Likelihood of Approval
Montelukast sodium is under clinical development by Jiangyin Berrysen Pharmaceutical and currently in Phase II for Radiation Injury. According to...
Montelukast sodium by Jiangyin Berrysen Pharmaceutical for Endometrial Cancer: Likelihood of Approval
Montelukast sodium is under clinical development by Jiangyin Berrysen Pharmaceutical and currently in Phase II for Endometrial Cancer. According to...